Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2023		Dec. 31, 2022
Assets
Investments, at fair value		$ 14,666.1	[1]	$ 15,377.3	[2]
Cash		171.0		248.0
Foreign currency, at fair value (cost—$5 and $3, respectively)		5.0		3.0
Receivable for investments sold and repaid		176.0		212.0
Income receivable		317.0		227.0
Unrealized appreciation on foreign currency forward contracts		21.0		25.0
Deferred financing costs		25.0		23.0
Prepaid expenses and other assets		3.0		9.0
Total assets		15,384.0		16,124.0
Liabilities
Payable for investments purchased		0.0		14.0
Debt (net of deferred financing costs of $27 and $34, respectively)	[3]	8,016.0		8,694.0
Unrealized depreciation on foreign currency forward contracts		0.0		1.0
Stockholder distributions payable		196.0		192.0
Management fees payable		56.0		59.0
Subordinated income incentive fees payable	[4]	47.0		27.0
Administrative services expense payable		6.0		6.0
Interest payable		79.0		90.0
Other accrued expenses and liabilities		14.0		29.0
Total liabilities		8,414.0		9,112.0
Commitments and contingencies	[5]
Stockholders’ equity
Preferred stock, $0.001 par value, 50,000,000 shares authorized, none issued and outstanding		0.0		0.0
Common stock, $0.001 par value, 750,000,000 shares authorized, 280,066,433 and 281,731,750 shares issued and outstanding, respectively		0.0		0.0
Capital in excess of par value		9,578.0		9,610.0
Retained earnings (accumulated deficit)	[6]	(2,608.0)		(2,598.0)
Total stockholders’ equity		6,970.0		7,012.0
Total liabilities and stockholders’ equity		$ 15,384.0		$ 16,124.0
Net asset value per share of common stock at period end (in dollars per share)		$ 24.89		$ 24.89
Non-controlled/unaffiliated investments
Assets
Investments, at fair value		$ 11,057.0		$ 12,026.0
Non-controlled/affiliated investments
Assets
Investments, at fair value		555.3		443.4
Controlled/affiliated investments
Assets
Investments, at fair value		$ 3,054.3		$ 2,908.4

[1] See Note 8 for additional information regarding the fair value of the Company’s financial instruments

[2] Fair value determined by the Company’s board of directors (see Note 8).

[3] See Note 9 for a discussion of the Company’s financing arrangements.

[4] See Note 2 and 4 for a discussion of the methodology employed by the Company in calculating the subordinated income incentive fees.

[5] See Note 10 for a discussion of the Company’s commitments and contingencies.

[6] See Note 5 for a discussion of the sources of distributions paid by the Company.